Praktische Anwendung von Katecholaminen

  • H. Stopfkuchen
Part of the Kinderanästhesie book series (KINDERANAESTHES)

Zusammenfassung

Katecholamine sind derzeit die bedeutsamsten pharmakologischen Substanzen zur Unterstützung des Kreislaufs im akuten kardiozirkulatorischen Versagen im Kindesalter.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Fowler MB, Lager JA, Hopkins GL, Minobe W, Bristow MR (1986) Assessment of the β-adrenerge receptor pathway in the infact fashing human heart, progressive receptor down-regulation and subsensitively to agonist response. Circulation 74: 1290–1302PubMedCrossRefGoogle Scholar
  2. 2.
    Hayes JS, Pollockand GD, Füller RW (1984) In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol. J Pharmacol Exp Ther 231: 633–639PubMedGoogle Scholar
  3. 3.
    Kliegman R, Fanaroff AA (1978) Caution in the use of dopamin in the neonate. J Pediatr 93: 540 (letter)Google Scholar
  4. 4.
    Kuschinsky G, Lüllmann H (1976) Kurzes Lehrbuch der Pharmakologie. Thieme, Stuttgart New YorkGoogle Scholar
  5. 5.
    Lang P, Williams RG, Norwood WI, Castaneda A (1980) The hemodynamic effects of dopamine in infants after corrective cardiac surgery. J Pediatr 96: 630–634PubMedCrossRefGoogle Scholar
  6. 6.
    Perkin RM, Levin DL, Webb R, Aguino A, Reedy J (1982) Dobutamine: A hemodynamic evaluation in children with shock. J Pediatr 100: 977–983PubMedCrossRefGoogle Scholar
  7. 7.
    Rapoport RM (1987) Effects of norepinephrine on contraction and hydrolysis of phosphatidylinositols in rat aorte. J Pharmacol Exp Ther 242: 188–194PubMedGoogle Scholar
  8. 8.
    Reinhardt D, Zehmisch T, Becker B, Nagel-Hiemke M (1984) Age-dependency of alpha-and beta-adrenoceptors on thrombocytes and lymphocytes of asthmatic and non-asthmatic children. Eur J Pediatr 142: 111–116PubMedCrossRefGoogle Scholar
  9. 9.
    Ruffolo RR, Yaden EL (1983) Vascular effects of the steroisomers of dobutamine. J Pharmacol Exp Ther 224: 46PubMedGoogle Scholar
  10. 10.
    Schranz D, Stopfkuchen H, Jüngst B-K, Clemens R, Emmrich P (1982) Hemodynamic effects of dobutamine in children with cardiovascular failure. Eur J Pediatr 139: 4–7PubMedCrossRefGoogle Scholar
  11. 11.
    Stopfkuchen H, Schranz D, Jüngst B-K (1984) Dobutamin im Kindesalter. Monatsschr Kinderheilkd 132: 17–20PubMedGoogle Scholar
  12. 12.
    Stopfkuchen H, Schranz D, Huth R, Jüngst B-K (1987) Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals. Eur J Pediatr 146: 135–139PubMedCrossRefGoogle Scholar
  13. 13.
    Zaritsky A, Chernow B (1984) Use of catecholamines in pediatrics. J Pediatr 105: 341–350PubMedCrossRefGoogle Scholar
  14. 14.
    Zaritsky AL, Lotze A, Stull R, Goldstein DS (1987) Dobutamine pharmacokinetics in critically ill infants. Crit Care Med 15: 436 (abstract)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • H. Stopfkuchen

There are no affiliations available

Personalised recommendations